Keywords: avastin, herceptin, her2, study, initiated, international, beth

Avastin + Herceptin HER2 study initiated

Article | 09 June 2008

Print This

The international BETH study for women with HER2-positive breast cancer is open for enrollment. The pivotal Phase III clinical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in